本文選題：兒童 + 血友病　； 參考：《中國(guó)實(shí)用兒科雜志》2017年01期

【摘要】：血友病診治得益于科學(xué)的進(jìn)步,作為一種可以致死、致殘的先天性凝血異常性疾病,血友病的關(guān)懷事業(yè)正在不斷進(jìn)步。目前,血友病已從一種威脅生命的疾病轉(zhuǎn)變?yōu)榻K生攜帶的疾病,臨床已看到了治愈的曙光。世界范圍內(nèi)兒童血友病關(guān)懷事業(yè)面臨的主要問(wèn)題是如何更加合理有效地開(kāi)展預(yù)防治療、如何有效防控抑制物。而隨著血友病關(guān)懷領(lǐng)域不斷涌現(xiàn)的創(chuàng)新性、革命性的新技術(shù)及產(chǎn)品,血友病的關(guān)懷理念和策略面臨不斷更新和挑戰(zhàn)。中國(guó)作為發(fā)展中國(guó)家,雖然兒童血友病關(guān)懷起步較晚,但進(jìn)展較快。應(yīng)用更加個(gè)性化的治療和新的技術(shù)產(chǎn)品,中國(guó)兒童血友病關(guān)懷事業(yè)將進(jìn)入新的時(shí)代。
[Abstract]:The diagnosis and treatment of Hemophilia benefits from the progress of science as a kind of congenital coagulopathy which can be fatal and disabled , and the cause of caring for Hemophilia is progressing . At present , Hemophilia has been transformed from a life - threatening illness to life - borne diseases . The main problem in the care of children in the world has been constantly updated and challenged . China , as a developing country , has made progress faster . With more personalized treatment and new technology products , the cause of caring for children in China will enter a new era .
【作者單位】： 首都醫(yī)科大學(xué)附屬北京兒童醫(yī)院血液腫瘤中心兒童血液病與腫瘤分子分型北京市重點(diǎn)實(shí)驗(yàn)室兒科學(xué)國(guó)家重點(diǎn)學(xué)科教育部?jī)嚎浦卮蠹膊⊙芯恐攸c(diǎn)實(shí)驗(yàn)室;
【分類(lèi)號(hào)】：R725.5
，

本文編號(hào)：1960391